Evaluation of the Compatibility of Moxifloxacin with Selected Excipients Used in the Formulation of Nanopharmaceuticals
Crossref DOI link: https://doi.org/10.1007/s11094-022-02556-8
Published Online: 2022-02-11
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Fahim Ullah
Nasir, Fazli
Hassan, Muhammad
Khan, Amjad
Ullah, Aman
Rabbi, Fazle
Shahbaz, Naila
Text and Data Mining valid from 2022-02-01
Version of Record valid from 2022-02-01
Article History
Received: 12 December 2020
First Online: 11 February 2022